{
    "2021-08-03": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Novartis announces lift of partial clinical trial hold and plans to initiate a new, pivotal Phase 3 study of intrathecal OAV-101 in older patients with SMA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "clinical trial hold lift",
                        "Phase 3 study",
                        "OAV-101",
                        "SMA"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}